Clinica e Investigacion en Ginecologia y Obstetricia, published by ELSEVIER ESPANA, serves as a prominent platform for researchers and professionals dedicated to advancing the fields of obstetrics, gynecology, and reproductive medicine. Established in 1976, this journal provides a valuable repository of knowledge, publishing original research and critical reviews that contribute significantly to the scientific community. Despite its current classification in the Q4 quartile of the Scopus rankings, it offers essential insights into contemporary clinical issues and emerging trends, relevant for both seasoned researchers and students alike. While the journal is not open access, its content remains crucial for understanding the evolving landscape of women's health. As it continues to operate until 2025, Clinica e Investigacion en Ginecologia y Obstetricia is dedicated to fostering dialog and discovery in vital healthcare practices, growing its readership and impact within the medical field.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, published by Wiley, is a leading journal in the field of obstetrics and gynecology that has been disseminating high-quality research since its inception. With an ISSN of 1341-8076 and an E-ISSN of 1447-0756, this journal thrives on contributing to this specialized area of medicine, showcasing innovations and advancements essential for practitioners and scholars alike. Notably, it holds a commendable Impact Factor reflective of its Q2 ranking in both Medicine and Obstetrics and Gynecology categories for 2023, placing it in the 55th percentile among its peers according to Scopus. The journal covers a wide array of topics pertinent to contemporary medical practices and research in Australia and beyond, aiming to foster interdisciplinary dialogue and advance clinical practices. Researchers, professionals, and students will find it an invaluable resource, featuring rigorous peer-reviewed articles that shed light on emerging trends, clinical guidelines, and groundbreaking studies. As it continues to converge on pivotal medical issues up until 2024, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH stands poised to make a lasting impact in the realm of women's health.

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Obstetrics & Gynecology Science is a premier journal in the field of obstetrics and gynecology, published by the Korean Society of Obstetrics and Gynecology (KSOG). With an ISSN of 2287-8572 and an E-ISSN of 2287-8580, this journal has established a solid reputation for disseminating high-quality research since its transition to an Open Access model in 2010. Situated in South Korea, the journal contributes significantly to the global academic discourse, evidenced by its categorization in Q2 for Obstetrics and Gynecology as of 2023, and its notable Scopus ranking of #75 out of 209 in the Medicine category, reflecting a commendable 64th percentile ranking. The scope of the journal covers diverse research areas relevant to both established practitioners and emerging scholars, aiming to foster innovation and knowledge transfer in women's health. As the journal converges its focus from 2017 to 2024, it continues to be an essential resource for researchers, healthcare professionals, and students dedicated to advancing their understanding and practice in this vital field of medicine.

Reproductive and Developmental Medicine is a pioneering open-access journal dedicated to advancing knowledge in the fields of reproductive medicine and developmental biology. Published by LIPPINCOTT WILLIAMS & WILKINS, the journal serves as a platform for researchers, clinicians, and graduate students alike, fostering collaboration and dissemination of innovative research findings. With an ISSN of 2096-2924 and E-ISSN 2589-8728, it has established a significant presence in the academic community since its inception in 2017. The journal is indexed in Scopus and achieved a category quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine as of 2023, highlighting its importance as a resource for cutting-edge studies and reviews in these vital areas. The journal's open-access model ensures that research is readily available to scholars and practitioners worldwide, thus enhancing the global discourse in reproductive health and development. This makes Reproductive and Developmental Medicine an invaluable resource for those dedicated to improving outcomes in obstetrics, gynecology, and reproductive health.

The INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, published by Wiley, stands as a prestigious and influential resource in the fields of medicine and obstetrics and gynecology. With its ISSN 0020-7292 and E-ISSN 1879-3479, this journal has been at the forefront of scholarly communication since its inception in 1973, extending its reach and impact through to 2024. Ranked in the Q1 quartile in both medicine miscellaneous and obstetrics and gynecology, and positioned impressively at 39th out of 209 in the Scopus rankings, the journal is renowned for its rigorous peer-reviewed articles that advance the understanding and practice of gynecological and obstetric health. The importance of this journal is underscored by its role in disseminating cutting-edge research and fostering innovation in clinical practices, making it an essential reading for researchers, healthcare professionals, and students alike. While it does not offer open access, its robust subscription model ensures a wealth of valuable information is accessible to those dedicated to improving women's health globally.

Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

HUMAN REPRODUCTION UPDATE, published by Oxford University Press, stands as a leading journal in the fields of Obstetrics and Gynecology and Reproductive Medicine. With an impressive Q1 ranking in both categories according to the 2023 category quartiles and a significant Scopus rank, it is recognized as one of the top journals globally in these disciplines, catering to the most relevant and cutting-edge research. The journal has been a crucial platform for disseminating vital findings and reviews from 1995 to 2024, contributing to advancements in human reproductive health. With its focus on publishing high-quality, peer-reviewed articles, it serves as an essential resource for researchers, healthcare professionals, and students seeking the latest insights and developments in reproductive science. As the journal aims to foster informed discussions and encourage further research, it remains committed to shaping the future of reproductive health and medicine.